InvestorsHub Logo
Followers 15
Posts 571
Boards Moderated 1
Alias Born 08/04/2011

Re: None

Friday, 04/24/2015 7:26:11 AM

Friday, April 24, 2015 7:26:11 AM

Post# of 1210
Stem Cell Stock Review.

"In our opinion, Accurexa’s end goal is to provide a device that can save lives, by radically improving the effectiveness of treating brain tumors - not by improving the drugs used to treat the tumor - but rather by improving the delivery method of those same drugs used to treat the tumor."

$ACXA $1.10

http://biotechstockreview.ning.com/profiles/blogs/accurexa-nears-launch-of-the-world-s-most-advanced-drug-delivery

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.